Rockwell Medical (RMTI) Invested Capital (2010 - 2026)

Rockwell Medical has reported Invested Capital for 17 years, with the latest figure at $36.5 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 10.97% year-over-year to $36.5 million; the trailing twelve-month figure through Mar 2026 stood at $36.5 million (up 10.97% YoY), and the FY2025 full-year result was $37.8 million, up 10.66% from the prior year.
• Invested Capital for Q1 2026 stood at $36.5 million, down from $37.8 million in the prior quarter.
• The five-year high for Invested Capital was $37.9 million in Q3 2025, with the low at -$1.8 million in Q1 2022.
• Historically, Invested Capital has averaged $25.1 million across 5 years, with a median of $23.7 million in 2023.
• Annual changes were most pronounced in 2022 — Invested Capital sank 106.67% — and 2023, when it jumped 919.19%.
• Rockwell Medical's Invested Capital stood at $23.3 million in 2022, then gained by 0.31% to $23.4 million in 2023, then surged by 45.93% to $34.1 million in 2024, then climbed by 10.66% to $37.8 million in 2025, then decreased by 3.28% to $36.5 million in 2026.
• The last three Invested Capital figures came in at $36.5 million (Q1 2026), $37.8 million (Q4 2025), and $37.9 million (Q3 2025), per Business Quant data.